polyomavirus
ki
kipyv
wu
wupyv
recent
discov
specimen
patient
respiratori
tract
infect
analyz
frequenc
clinic
impact
cohort
pediatr
patient
german
univers
children
hospit
nasopharyng
aspir
bronchoalveolar
lavag
specimen
children
acut
respiratori
tract
infect
screen
kipyv
wupyv
use
polymeras
chain
reactionbas
method
kipyv
detect
wupyv
patient
without
coinfect
respiratori
virus
codetect
cmv
ebv
hhv
one
immunocompromis
patient
small
proport
posit
sampl
kipyv
wupyv
document
studi
clinic
relev
virus
remain
unclear
requir
evalu
sinc
increas
number
new
respiratori
virus
detect
children
respiratori
tract
infect
rti
includ
human
metapneumoviru
hmpv
human
bocaviru
hbov
recent
two
novel
polyomavirus
detect
respiratori
secret
alland
et
al
discov
previous
unrecogn
human
polyomaviru
nasopharyng
aspir
npa
fecal
sampl
propos
new
ki
polyomaviru
kipyv
second
newli
identifi
polyomaviru
describ
gaynor
et
al
respiratori
sampl
brisban
australia
st
loui
usa
author
amplifi
clone
genom
wu
polyomaviru
wupyv
npa
patient
pneumonia
without
detect
respiratori
pathogen
screen
patient
rti
yield
addit
posit
patient
sinc
first
descript
kipyv
wupyv
number
preval
studi
variou
area
publish
clinic
relev
rti
children
remain
unresolv
issu
studi
retrospect
investig
npa
children
acut
rti
presenc
kipyv
wupyv
dna
major
aim
elucid
frequenc
novel
virus
identifi
case
may
clinic
interest
nasopharyng
aspir
bronchoalveolar
lavag
specimen
children
admit
hospit
acut
respiratori
tract
diseas
sent
depart
virolog
univers
bonn
januari
decemb
sampl
aliquot
prepar
dnarna
store
follow
clinic
pictur
cours
defin
acut
respiratori
tract
diseas
bronchiti
bronchiol
central
pneumonia
lobar
pneumonia
lower
respiratori
tract
infect
document
pneumonia
chest
xray
confirm
clinic
diagnosi
sampl
prospect
examin
rsv
influenza
virus
b
coronaviru
rhinoviru
adenoviru
hmpv
hbov
antigen
detect
pcr
rtpcr
describ
previous
dna
pcr
detect
kipyv
wupyv
prepar
nasopharyng
aspir
use
qiamp
viral
dna
kit
qiagen
follow
manufactur
instruct
rna
viru
detect
rna
extract
use
qiamp
viral
rna
kit
qiagen
hilden
germani
pcr
amplif
perform
reaction
mixtur
follow
condit
pmol
primer
lm
deoxynucleosid
triphosph
mm
trishcl
ph
mm
kcl
mm
mgcl
u
taq
dna
polymeras
roch
germani
reaction
run
biometra
thermocycl
use
step
cycl
programm
initi
denatur
dna
min
cycl
run
min
anneal
temperatur
min
min
extens
cycl
aliquot
reaction
run
nusiev
electrophoresisgrad
agaros
gel
fmc
bioproduct
rockland
main
usa
tae
buffer
moll
tri
acet
moll
edta
ethidium
bromid
gml
visual
amplifi
pcr
product
uv
illumin
primer
sequenc
taken
origin
descript
kipyv
wupyv
procedur
avoid
contamin
strictli
follow
dnarna
isol
prepar
reaction
mixtur
amplif
analysi
physic
separ
perform
three
differ
room
positivedisplac
tip
use
manipul
neg
control
contain
reaction
mixtur
without
dna
alway
done
kipyv
wupyv
dna
detect
npa
specimen
patient
kipyv
n
wupyv
n
codetect
cmv
ebv
hhv
one
immunocompromis
patient
common
respiratori
virus
found
children
rsv
n
hmpv
n
influenza
viru
n
coronaviru
n
hbov
n
kipyv
case
descript
girl
admit
hospit
novemb
fatigu
polydypsia
polyuria
anogenit
candidiasi
primari
manifest
diabet
type
diagnos
insulin
treatment
start
immedi
treatment
complic
fever
sign
acut
rti
day
viral
respiratori
pathogen
detect
nasopharyg
aspir
except
kipyv
retrospect
day
patient
discharg
good
condit
without
respiratori
symptom
kipyv
case
descript
girl
highrisk
acut
myeloid
leukemia
admit
bone
marrow
transplant
bmt
graftversushost
prophylaxi
done
cyclosporin
switch
mycophenol
mofetil
tacrolimu
suspect
sever
acut
graftversushost
diseas
skin
gastrointestin
tract
day
transplant
colonoscopi
reveal
crohnlikediseas
treatment
mesalazin
etanercept
cortison
start
day
may
patient
display
respiratori
distress
chest
xray
examin
show
leftsid
basal
pneumonia
antimicrobi
treatment
includ
antifung
start
addit
ganciclovir
ad
detect
cytomegaloviru
ebv
bronchoalveolar
lavag
specimen
number
copi
quantit
dna
test
found
low
pathogen
respiratori
virus
detect
except
kipyv
retrospect
symptom
acut
rti
improv
follow
day
patient
discharg
hospit
good
clinic
condit
month
bmt
wupyv
case
descript
girl
admit
hospit
octob
acut
bronchiti
viral
pathogen
detect
nasopharyg
aspir
except
wupyv
retrospect
patient
receiv
inhal
salbutamol
ipatropium
bromid
budesonid
well
montelukast
oral
medic
patient
discharg
day
salbutamol
montelukast
continu
low
preval
polyomaviru
ki
wu
dna
npa
specimen
pediatr
patient
acut
rti
seri
confirm
exclud
pathogen
role
newli
describ
virus
one
hand
may
due
rel
low
sensit
method
detect
copi
per
ml
npa
hand
may
also
caus
lack
kipyv
wupyv
patient
cohort
preval
studi
kipyv
wupyv
report
worldwid
distribut
incid
kipyv
sweden
uk
thailand
australia
preval
wupyv
highest
south
korea
thailand
australia
us
uk
preval
respect
report
age
distribut
kipyvand
wupyvinfect
patient
show
two
peak
highest
rate
children
year
patient
older
year
season
variat
kipyv
wupyv
consist
demonstr
infect
kipyv
detect
winter
month
thailand
studi
conduct
australia
australia
incid
wupyv
infect
show
highest
peak
decemb
confirm
studi
thailand
detect
kipyv
wupyv
frequent
associ
coinfect
respiratori
virus
high
codetect
rate
found
australia
kipyv
wupyv
common
copathogen
human
rhinoviru
hbov
codetect
kipyv
wupyv
occur
patient
one
case
respiratori
viru
present
norja
et
al
detect
kipyv
wupyv
patient
viral
coinfect
patient
predomin
codetect
adenoviru
overal
frequenc
detect
kipyv
wupyv
equal
patient
upper
lower
respiratori
tract
infect
asymptomat
patient
eight
patient
immunocomprom
studi
find
coinfect
respiratori
virus
three
patient
kipyv
wupyv
infect
patient
symptom
arti
clinic
relev
virus
cmv
ebv
hhv
codetect
one
sever
immunocompromis
patient
bronchoalveolar
lavag
specimen
unclear
nevertheless
coinfect
still
remain
possibl
abl
test
put
copathogen
amount
viral
nucleic
acid
present
sampl
may
fallen
detect
limit
pathogen
henc
care
suggest
kipyv
wupyv
viral
colon
limit
studi
examin
children
without
acut
respiratori
symptom
unknown
whether
kipyv
wupyv
persist
host
may
reactiv
case
immunosuppress
similar
jcv
bkv
furthermor
whether
virus
display
oncogen
potenti
describ
human
anim
polyomavirus
remain
unclear
need
evalu
howev
koch
modifi
postul
yet
fulfil
far
controversi
whether
kipyv
wupyv
inde
respiratori
pathogen
rather
innoc
bystand
studi
requir
evalu
clinic
relev
detect
kipyv
wupyv
respiratori
specimen
